Profile
HDAX Therapeutics is pioneering best-in-class therapeutics for neurological and cardiovascular diseases. Leveraging its unique molecular recognition platform technology, it engineered a novel 2-site binding mechanism targeting HDAC6, a key protein implicated in microtubule dysfunction. Its approach addresses critical drug-design obstacles, including weak-binding, off-target toxicities, and suboptimal pharmacokinetic profiles, unlocking the potential to translate into better treatments for patients. HDAX’s initial focus is peripheral neuropathies (CIPN and CMT), with additional applications in heart failure and neurodegeneration.
Event details
Date: January 8 - 10, 2024
Event contact
Patricia Cosgrove
Area Director
USA: Life Sciences
Tel: +1 647-293-6306
Email: patricia.cosgrove@ontario.ca
Participants
18 in total
-
Allarta Life Science is a pre-clinical life science platform company developing next-generation biomaterials for… -
Canurta stands at the forefront of biotechnological innovation, developing new small-molecule therapeutics from… -
Enhanced Medical Nutrition (EMN) is a life sciences company that develops medical food products to… -
For more than 20 years, GL CHEMTEC International (“GLC”) has been a leading chemistry-… -
HDAX Therapeutics is pioneering best-in-class therapeutics for neurological and cardiovascular diseases.… -
ImmunoBiochem is an innovative biopharmaceutical company on a mission to develop novel biological therapeutics to… -
Iseehear Inc. pioneers transformative data management solutions for the Life Sciences community. It optimizes… -
Mannin Research stands at the forefront of innovation, driving the development of the groundbreaking Ang1-C4bp… -
Mediphage has developed a proprietary and scalable E. coli-based manufacturing process for the production of… -
Nucro-Technics is a full-service contract support organization that specializes in the conduct of both GLP… -
panCELLa is focused on engineering cells with total control to provide safe and effective cells in an economically… -
Pattern Pharma’s patent-protected immunotherapeutic, PPI-100, mobilizes innate immunity by targeting… -
PolyAnalytik is a contract research organization that specializes in the analysis and purification of medical… -
PurMinds is a neuro-medicine development and API supply company focused on the treatment of neurological… -
QurCan Therapeutics is a biotechnology company that has developed the next-generation nanoparticle for safer and… -
The need for tools to optimize treatment based on a patient's personal response to treatment is critical for the… -
At Specific Biologics, its mission is to develop therapeutics to treat or cure disease through precision gene editing… -
Spiderwort is a platform biomaterials company developing a suite of cellulose-based scaffolds for use in a number of…